Domov › Akútna biphenotypová leukémia › Kalifornia

Klinické štúdie Akútna biphenotypová leukémia v štáte Kalifornia

15 štúdií pre Akútna biphenotypová leukémia hľadá účastníkov v zariadeniach v štáte Kalifornia.

Mestá v štáte Kalifornia

Oficiálny text štúdie (anglicky)

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

City of Hope, Duarte
UC Davis, Sacramento
Stanford Health Care, Stanford

Prebieha náborFáza 1

Vek 12 až 78 · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT03802695

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Loma Linda University Medical Center, Loma Linda
Miller Children's and Women's Hospital Long Beach, Long Beach
UCSF Benioff Children's Hospital Oakland, Oakland
a 4 ďalších

Prebieha náborFáza 2

365 Days · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06317662

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Kaiser Permanente Downey Medical Center, Downey
City of Hope Comprehensive Cancer Center, Duarte
Loma Linda University Medical Center, Loma Linda
a 14 ďalších

Prebieha náborFáza 3

365 Days – 25 Years · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Kaiser Permanente Downey Medical Center, Downey
Loma Linda University Medical Center, Loma Linda
Miller Children's and Women's Hospital Long Beach, Long Beach
a 8 ďalších

Prebieha náborFáza 1/2

Do veku 22 · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT04726241

Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)

Rady Children's Hospital, San Diego

Prebieha náborFáza 2

Vek 1 až 18 · Všetky pohlavia · Aktualizované 10. 8. 2026 · NCT06390319

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

City of Hope, Duarte
Valkyrie Clinical Trials, Los Angeles

Prebieha náborFáza 1/2

Vek 13 až 90 · Všetky pohlavia · Aktualizované 6. 8. 2026 · NCT06533579

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Rady Children's Hospital, San Diego

Prebieha náborFáza 1

Vek 1 až 30 · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT06177067

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

Rady Children's Hospital, San Diego

Prebieha náborFáza 4

Vek 1 až 18 · Všetky pohlavia · Aktualizované 14. 7. 2026 · NCT06289673

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

UCLA Department of Medicine, Los Angeles

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 7. 7. 2026 · NCT07216443

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

Stanford University, Palo Alto

Prebieha náborFáza 1

Vek 18 až 70 · Všetky pohlavia · Aktualizované 23. 6. 2026 · NCT06551584

A Study of Revumenib and Mezigdomide in People With Leukemia

City of Hope Cancer Center (Data collection only), Duarte

Prebieha náborFáza 1/2

Vek 12 a viac · Všetky pohlavia · Aktualizované 22. 6. 2026 · NCT07356154

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

City of Hope, Duarte
Los Angeles Cancer Network, Los Angeles
UCLA Medical Center of Hematology/Oncology, Los Angeles
a 1 ďalších

Prebieha náborFáza 1/2

Vek 12 až 95 · Všetky pohlavia · Aktualizované 15. 4. 2026 · NCT04329728

Venetoclax Basket Trial for High Risk Hematologic Malignancies

University of California San Francisco-Benioff Children's Hospital, San Francisco

Prebieha náborFáza 1

Vek 1 až 40 · Všetky pohlavia · Aktualizované 12. 3. 2026 · NCT05292664

Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant

City of Hope Medical Center, Duarte

Prebieha náborFáza 1

Vek 2 a viac · Všetky pohlavia · Aktualizované 5. 3. 2026 · NCT06575296

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Children's Hospital Los Angeles, Los Angeles
Children's Hospital Orange County, Orange
UCSF School of Medicine, San Francisco

Prebieha náborFáza 1

Vek 1 až 21 · Všetky pohlavia · Aktualizované 6. 12. 2024 · NCT05476770

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.